Why Moderna: Largest pure-play mRNA pipeline beyond COVID-19.
The idea
An index of biotech companies built around mRNA platforms, vaccines, oncology, rare disease, and protein replacement therapies.
Made 30 Apr 2026. Refreshed every 6 months.
Discussion
What stocks are in mRNA Platform Index?
It holds 8 companies. The largest are Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), Beam Therapeutics (BEAM) and Vertex Pharmaceuticals (VRTX), followed by ARCT, TBPH and PSTX. Most of the money is in healthcare.
How has mRNA Platform Index performed?
+4.0% over the past year against +29.4% for the S&P 500, −44.6% over five years in the backtest. Results before the creation date are simulated from real past prices and leave out fees and taxes. Past performance is not a guide to the future.
How is mRNA Platform Index weighted?
Every company gets the same share. The biggest holding is Moderna (MRNA) at 12.5%.
Can I invest in mRNA Platform Index?
It is not a fund you can buy. It is a list of shares you can buy yourself at your broker, and Arithmos shows you how for more than 40 brokers, or creates it as a Trading 212 pie. Arithmos is a research tool, not investment advice.
Backtests, risk ratios, how it was built and more are in Complex mode.
More detail
What’s inside
8 companies. The biggest is Moderna at 13%.
Percentages are target weights at the last rebalance.
Weighting: equalRebalance: semiannual
Company pages
Each company’s price history, and the other portfolios that hold it.
Results before a portfolio’s creation date are simulated from real historical prices and don’t include fees, taxes or trading costs. How we calculate performance. Investing puts your money at risk: you can lose some or all of it. Nothing here is investment advice.
Want the short version? Simple mode shows just the essentials.